Fetal hydrops

Gene: GLE1

Red List (low evidence)

GLE1 (GLE1, RNA export mediator)
EnsemblGeneIds (GRCh38): ENSG00000119392
EnsemblGeneIds (GRCh37): ENSG00000119392
OMIM: 603371, Gene2Phenotype
GLE1 is in 8 panels

2 reviews

Rebecca Foulger (Genomics England curator)

Comment on list classification: Kept rating as red based on Reviewer comments, and localization of disorder to Finnish population.
Created: 16 Dec 2016, 10:28 a.m.
LAAHD (OMIM:618890) and LCCS (OMIM:253310) are allelic disorders. LCCS is always fatal during the fetal period and presents with severe hydrops. Infants with LAAHD survive longer than those with LCCS, and when present, hydrops are mild (See PMID:7821908, Vuopala et al., 1995). Both are disorders of the Finnish population.
Created: 16 Dec 2016, 10:27 a.m.
Comment on mode of inheritance: Mode of inheritance confirmed on OMIM for LCCS1 (OMIM:253310) and G2P for LAAHD (OMIM:611890).
Created: 16 Dec 2016, 10:25 a.m.
GLE1 is included in the gene panel for Fetal hydrops because there is evidence that lethal congenital contracture syndrome-1 (LCCS1) is caused by mutations in GLE1, and Fetal hydrops is a clinical feature of LCCS1. Note that PMID:16892327 report that LCCS1 is a disorder of the Finnish population.
Created: 10 Oct 2016, 12:39 p.m.

Diana Wellesley (nhs)

I don't know

Primarily a disorder in people of Finnish extraction with a common severe splicing mutation. Would seem to be rarely seen outside this population. Only the one reference to hydrops.
Created: 22 Nov 2016, 10:26 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Arthrogryposis, lethal, with anterior horn cell disease OMIM 611890 as well as LCCS1 OMIM 253310

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Red
  • Other
Phenotypes
  • Lethal congenital contracture syndrome 1, 253310
  • LCCS1
  • MULTIPLE CONTRACTURE SYNDROME, FINNISH TYPE
  • Arthrogryposis, lethal, with anterior horn cell disease, 611890
OMIM
603371
Clinvar variants
Variants in GLE1
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

21 Dec 2016, Gel status: 1

panel promoted to version 1

Rebecca Foulger (Genomics England curator)

21 December 2016. External reviews were assessed, and panel was revised according to expert review, internal discussion and additional curation. Following internal discussion, all genes from the V1.14 'RASopathies' panel were added as green EXCLUDING NF1 and SPRED1- a cautious approach was taken because Fetal hydrops is a fetal panel. All relevant genes from the 'Mucopolysaccharideosis, Gaucher, Fabry' V1.0 panel (lysosomal storage disorders) were also added to the Fetal hydrops panel as green together with genes from the literature where there is a reasonable link between the corresponding lysosomal storage disorder (LSD) and Fetal hydrops. All PEX genes from the V1.2 'Peroxisomal disorders' panel were added as green based on a link between peroxisomal biogenesis disorders and Fetal hydrops.

16 Dec 2016, Gel status: 1

Gene classified by Genomics England curator

Rebecca Foulger (Genomics England curator)

This gene has been classified as Red List (Low Evidence).

16 Dec 2016, Gel status: 0

Set Mode of Inheritance

Rebecca Foulger (Genomics England curator)

Mode of inheritance for GLE1 was changed to BIALLELIC, autosomal or pseudoautosomal

16 Dec 2016, Gel status: 0

Set publications

Rebecca Foulger (Genomics England curator)

Publications for GLE1 were set to 3993672; 3344776; 7966188; 16892327

16 Dec 2016, Gel status: 0

Set Phenotypes

Rebecca Foulger (Genomics England curator)

Phenotypes for GLE1 were set to Lethal congenital contracture syndrome 1, 253310; LCCS1; MULTIPLE CONTRACTURE SYNDROME, FINNISH TYPE; Arthrogryposis, lethal, with anterior horn cell disease, 611890

10 Oct 2016, Gel status: 0

Created

Rebecca Foulger (Genomics England curator)

GLE1 was created by rfoulger

10 Oct 2016, Gel status: 0

Added New Source

Rebecca Foulger (Genomics England curator)

GLE1 was added to Fetal hydropspanel. Sources: Other